The hardening of arteries is a hallmark of atherosclerosis, an often deadly disease in which plaques, excessive connective tissue, and other changes build up inside vessel walls and squeeze off the flow of oxygen-rich blood throughout the body. Now, researchers at our Diabetes and Obesity Research Center have described the molecular and cellular pathway that leads to this hardening of the arteries—and zeroed in on a particularly destructive protein called Dkk1.
Their study was published online today by Arteriosclerosis, Thrombosis, and Vascular Biology. The findings suggest that the development of drug therapies to selectively inhibit endothelial Dkk1 signaling may help limit arteriosclerotic disease.















That still frustrates me. As I’ve pointed out to countless people in the years since, with all we know about the human body, it’s surprising that cause of death can still be a mystery. “Heart failure” just seems like a catch-all phrase – an easy thing to say when there’s no other explanation. After all, isn’t that what kills us all in the end?
